United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
498.65
-15.17 (-2.95%)
Mar 3, 2026, 4:00 PM EST - Market closed

United Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,3351,195984.8727.3475.8
Depreciation & Amortization
85.672.553.251.349.9
Stock-Based Compensation
147.714439.1106.8138.5
Other Adjustments
99.7-88.4-65.758.3108.2
Change in Receivables
-70.9-0.4-58.5-21.7-41.3
Changes in Inventories
-52.6-46.9-13.6-13.4-7.5
Changes in Accounts Payable
97.942.757.144.5-12.5
Changes in Other Operating Activities
-80.98.5-18.4-150.6-112.9
Operating Cash Flow
1,5611,327978802.5598.2
Operating Cash Flow Growth
17.64%35.70%21.87%34.15%-20.84%
Capital Expenditures
-520.5-246.5-230.4-138.8-120.8
Purchases of Intangible Assets
-5.5----
Purchases of Investments
-3,460-1,677-2,514-1,710-1,895
Proceeds from Sale of Investments
3,4462,3692,1371,0371,529
Payments for Business Acquisitions
---89.2--
Other Investing Activities
-10.4-28.5-23--
Investing Cash Flow
-551.3417.2-719.6-811.5-486.9
Short-Term Debt Issued
200--800-
Short-Term Debt Repaid
-500-400-100-800-
Net Short-Term Debt Issued (Repaid)
-300-400-100--
Issuance of Common Stock
183.1160.1104.694.355.6
Repurchase of Common Stock
-1,000-1,000---
Net Common Stock Issued (Repurchased)
-816.9-839.9104.694.355.6
Other Financing Activities
-33.1-14.9-16.5-18.9-10.8
Financing Cash Flow
-1,150-1,255-11.975.444.8
Net Cash Flow
-140.1489.5246.566.4156.1
Free Cash Flow
1,0411,081747.6663.7477.4
Free Cash Flow Growth
-3.69%44.54%12.64%39.02%-31.45%
FCF Margin
32.70%37.55%32.12%34.28%28.32%
Free Cash Flow Per Share
21.7322.2815.0413.6810.09
Levered Free Cash Flow
564.2625.4732.7520.3272
Unlevered Free Cash Flow
691.78899.6763.61542.56241.56
Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q